(Adds details and background throughout)
Oct 16 (Reuters) - Biotech firm Prothena Corp PRTA.O
is preparing for a potential sale, Bloomberg News reported on
Monday, citing people with knowledge of the matter.
The Dublin, Ireland-based drugmaker has been speaking to
advisers as it prepares to explore options that may include a
sale or partnership, the report said.
Prothena did not immediately respond to a Reuters
request for comment.
Shares of the company were up 24% at $54.71.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh
Kuber)
((Sriparna.Roy@thomsonreuters.com;))